Investing.com — IDEXX Laboratories (NASDAQ:IDXX) shares jumped more than 8% on Monday after the company reported explosive Q4 earnings.
The Westbrook, Maine-based company's Q4 EPS came in at $2.32, above the consensus estimate of $2.12. Revenue grew 9% year-over-year to $901.6 million, beating the consensus estimate of $891.08M.
IDEXX Labs' extraordinary performance was seen in advance by our AI-powered stock-picking toll: ProPicks. The company has been an integral part of our Beat the S&P 500 strategy since November 2023, a period in which the stock alone posted an impressive 44% performance as the full strategy gained a solid 20%.
Looking forward to fiscal year 2024, the company expects EPS in the range of $10.84-$11.33, compared to the consensus estimate of $11.00. Revenue is seen at $3.93-4.04 billion, compared to the consensus of $3.97B.
IDXX is just one stock from a robust selection of 70+ companies distributed across our six market-beating strategies. The true key to our outperformance is the resilience of our carefully curated list of winners—not solely reliant on individual picks.
For investors looking to capitalize on such market opportunities, InvestingPro's AI-powered strategies offer a data-driven approach to stock selection. With these tools, investors can navigate the market with confidence, backed by the power of AI analysis.
Want to see all 20 stocks from the Beat the S&P 500 strategy and all other strategies? Subscribe here and never miss a bull market again!